KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Zoetis (ZTS) over the last 14 years, with Q3 2025 value amounting to $19.0 million.

  • Zoetis' Asset Writedowns and Impairment fell 3448.28% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $97.0 million for FY2024, which is 1565.22% down from last year.
  • According to the latest figures from Q3 2025, Zoetis' Asset Writedowns and Impairment is $19.0 million, which was down 3448.28% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, Zoetis' Asset Writedowns and Impairment registered a high of $35.0 million during Q3 2023, and its lowest value of $9.0 million during Q1 2022.
  • In the last 5 years, Zoetis' Asset Writedowns and Impairment had a median value of $18.0 million in 2022 and averaged $20.4 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 7755.1% in 2021, then surged by 14545.45% in 2022.
  • Quarter analysis of 5 years shows Zoetis' Asset Writedowns and Impairment stood at $11.0 million in 2021, then surged by 145.45% to $27.0 million in 2022, then rose by 22.22% to $33.0 million in 2023, then dropped by 21.21% to $26.0 million in 2024, then fell by 26.92% to $19.0 million in 2025.
  • Its Asset Writedowns and Impairment was $19.0 million in Q3 2025, compared to $15.0 million in Q2 2025 and $18.0 million in Q1 2025.